Skip Navigation LinksHome > August 2005 - Volume 11 - Issue 4, Stroke Prevention > USE OF ANTIPLATELET AGENTS FOR THE PREVENTION OF FIRST AND R...
CONTINUUM: Lifelong Learning in Neurology:
doi: 10.1212/01.CON.0000293701.92969.62
Article

USE OF ANTIPLATELET AGENTS FOR THE PREVENTION OF FIRST AND RECURRENT STROKE

Gorelick, Philip B.

Collapse Box

Abstract

Antiplatelet agents are an important component of the neurologist's armamentarium for stroke prevention. This chapter reviews major antiplatelet agents that are approved by the US Food and Drug Administration for stroke prevention. The discussion focuses primarily on the efficacy, safety, and cost of the following agents in recurrent stroke prevention: aspirin, aspirin plus extended-release dipyridamole, clopidogrel, and ticlopidine. The use of aspirin in prevention of a first stroke will also be discussed as will the concepts of aspirin "resistance" and "failure."

© 2005 American Academy of Neurology

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.

Login